Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia

Daniel J. Zheng, Gary Hettinger, Lusha Cao, Caitlin W. Elgarten, Brian T. Fisher, Cody Gathers, Yuan-Shung V. Huang, Jennifer Ko, Kasey Leger, Yimei Li, Regina M. Myers, Hari K. Narayan, Jose Ortiz, Alix E. Seif, Richard Aplenc, Kelly D. Getz

Blood (2024) 144 (Supplement 1): 116.

https://doi.org/10.1182/blood-2024-208120

Published: 2024

Journal Articles

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Blood (2024) 144 (Supplement 1): 531.

https://doi.org/10.1182/blood-2024-198385

Published: 2024

Journal Articles

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Ali Farrokhi, Tanmaya Atre, Samuel Salitra, Maryam Aletaha, Ana Citlali Márquez, Matthew Gynn, Mario Fidanza, Sumin Jo, Nina Rolf, Karen Simmons, Jesus Duque-Afonso, Michael L. Cleary, Alix E. Seif, Tobias Kollmann, Soren Gantt, Gregor S. D. Reid

Blood (2024) 144 (8): 809–821.

https://doi.org/10.1182/blood.2024025038

Published: 2024

Includes: Supplemental data

Journal Articles

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2430.

https://doi.org/10.1182/blood-2023-189240

Published: 2023

Journal Articles

Comparative Effectiveness of Reinduction Approaches for Pediatric Relapsed Acute Myeloid Leukemia

Caitlin W. Elgarten, Regina M. Myers, Alix E. Seif, Yimei Li, Daniel J. Zheng, Naomi J Winick, Elaine Morgan, Rajen Mody, Arunkumar Modi, Tamara P. Miller, Kelly Maloney, Mallorie M. Heneghan, M. Monica Gramatges, Brian T. Fisher, Kelly D. Getz, Richard Aplenc

Blood (2023) 142 (Supplement 1): 551.

https://doi.org/10.1182/blood-2023-188044

Published: 2023

Journal Articles

Differences in Absolute Neutrophil Count Eligibility Criteria of Pediatric Phase I and Phase I/II Oncology Clinical Trials According to Sponsorship

Rebecca Kelly, Jenny Ruiz, Richard Aplenc, Theodore W. Laetsch, Alix E. Seif

Blood (2023) 142 (Supplement 1): 7327.

https://doi.org/10.1182/blood-2023-186392

Published: 2023

Journal Articles

Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia

Regina M. Myers, Sarah Mumanachit, Shannon L. Maude, Amanda M. Dinofia, Jason L. Freedman, Nancy Bunin, Lisa Wray, Allison Barz Leahy, Timothy S Olson, Stephan Grupp, Alix E. Seif, Caitlin W. Elgarten

Blood (2023) 142 (Supplement 1): 3767.

https://doi.org/10.1182/blood-2023-188047

Published: 2023

Journal Articles

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 387.

https://doi.org/10.1182/blood-2023-180713

Published: 2023

Journal Articles

Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials

Jenny Ruiz, Yimei Li, Yuan-Shung V. Huang, Lusha Cao, Vicky Tam, Heather M. Griffis, Lena E. Winestone, Brian T. Fisher, Todd A. Alonzo, Anders E. Kolb, Karen Glanz, Kelly D. Getz, Richard Aplenc, Alix E. Seif

Blood (2022) 140 (Supplement 1): 11029–11031.

https://doi.org/10.1182/blood-2022-163573

Published: 2022

Journal Articles

Influence of Household Income on Health-Related Quality of Life in Children with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 11001–11003.

https://doi.org/10.1182/blood-2022-160336

Published: 2022

Journal Articles

Standardization in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL): Semiquantitative, Universally Applicable Flow Cytometric Criteria for Immunophenotypic Lineage Assignment and Isolated MPO

Alexandra E. Kovach, Sunil S. Raikar, Matthew J. Oberley, Gerald Wertheim, Karen R Rabin, Jyotinder N. Punia, Alix E. Seif, Reuven J Schore, Dragos C. Luca, Terri Guinipero, William G Woods, Viviane Cahen, Maurice R.G. O'Gorman, Etan Orgel, Brent L. Wood

Blood (2021) 138 (Supplement 1): 4475.

https://doi.org/10.1182/blood-2021-154295

Published: 2021

Journal Articles

Comprehensive Secretome Profiling Elucidates Novel Disease Biology and Identifies Pre-Infusion Candidate Biomarkers to Predict the Development of Severe Cytokine Release Syndrome in Pediatric Patients Receiving CART19

Blood (2021) 138 (Supplement 1): 167.

https://doi.org/10.1182/blood-2021-149477

Published: 2021

Journal Articles

Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Lena E. Winestone, MD, Kelly D Getz, Kira O Bona, MDMPH, Brian T. Fisher, DO, MSCE, Alan S Gamis, MD MPH, Alix E. Seif, MD, Lillian Sung, MD PhD, Yi-Cheng Wang, Todd A. Alonzo, PhD, Richard Aplenc, MD PhD

Blood (2019) 134 (Supplement_1): 703.

https://doi.org/10.1182/blood-2019-130978

Published: 2019

Journal Articles

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

Alix E. Seif, MD, Yimei Li, PhD, Viviane C. Cahen, Yuan-Shung V. Huang, MS, Matt Hall, PhD, E. Anders Kolb, MD, Brian T. Fisher, DO, MSCE, Richard Aplenc, MD PhD, Kelly D Getz

Blood (2019) 134 (Supplement_1): 3496.

https://doi.org/10.1182/blood-2019-122887

Published: 2019

Journal Articles

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Viviane C. Cahen, Yimei Li, PhD, Evanette Burrows, MPH, Caitlin W Elgarten, MD, Amanda M. DiNofia, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, M. Monica Gramatges, MD PhD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Kelly D Getz, PhD, Richard Aplenc, MD PhD, Alix E. Seif, MD

Blood (2018) 132 (Supplement 1): 3597.

https://doi.org/10.1182/blood-2018-99-114235

Published: 2018

Journal Articles

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Gerald Wertheim, MD, PhD, Sunil S. Raikar, MD, Jemily Malvar, Richard Sposto, PhD, Jyotinder N. Punia, MD, Karen R. Rabin, MD PhD, Alix E. Seif, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, Terri Guinipero, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 4080.

https://doi.org/10.1182/blood-2018-99-117377

Published: 2018

Journal Articles

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Matthew J. Oberley, MD PhD, Sunil S. Raikar, MD, Jemily Malvar, Gerald Wertheim, MD, PhD, Alix E. Seif, MD, Terri Guinipero, MD, Richard Sposto, PhD, Karen R. Rabin, MD PhD, Jyotinder N. Punia, MD, Reuven J. Schore, MD, Dragos C. Luca, MD, William G. Woods, MD, Maurice R.G. O'Gorman, MD PhD, Etan Orgel, MD MS

Blood (2018) 132 (Supplement 1): 558.

https://doi.org/10.1182/blood-2018-99-113606

Published: 2018

Journal Articles

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Amanda M. Li, MD, George E Hucks, Amanda M. Dinofia, MD, Alix E. Seif, MD, David T Teachey, MD, Diane Baniewicz, Colleen Callahan, Christina Fasano, Beth McBride, Vanessa Gonzalez, Farzana Nazimuddin, MS, David L. Porter, MD, Simon F Lacey, PhD BS, Carl H June, MD, Stephan A. Grupp, MD PhD, Shannon L. Maude, MD PhD

Blood (2018) 132 (Supplement 1): 556.

https://doi.org/10.1182/blood-2018-99-112572

Published: 2018

Journal Articles

Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort

Viviane C. Cahen, Yimei Li, PhD, Caitlin W Elgarten, MD, Amanda M. DiNofia, MD, Jennifer J. Wilkes, MD, Lena E. Winestone, MD, Yuan-Shung V. Huang, MS, M. Monica Gramatges, MD PhD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Kelly D Getz, PhD, Richard Aplenc, MD PhD, Alix E. Seif, MD

Blood (2018) 132 (Supplement 1): 624.

https://doi.org/10.1182/blood-2018-99-114228

Published: 2018

Journal Articles

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Lena E. Winestone, MD MSHP, Kelly D Getz, PhD, Yimei Li, PhD, Evanette Burrows, MPH, Michael Scheurer, MPH, PhD, M. Monica Gramatges, MD PhD, Jennifer J. Wilkes, MD, Tamara P. Miller, MDMSc, Alix E. Seif, MD, Robert W. Grundmeier, MD, Karen R. Rabin, MD PhD, Brian T. Fisher, DO, Richard Aplenc, MD PhD

Blood (2018) 132 (Supplement 1): 369.

https://doi.org/10.1182/blood-2018-99-120076

Published: 2018

NARROW

Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia

Real-World Generalizability of Clinical Trial Cytomolecular Features By Race and Ethnicity in Pediatric Acute Myeloid Leukemia (AML)

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia

Comparative Effectiveness of Reinduction Approaches for Pediatric Relapsed Acute Myeloid Leukemia

Differences in Absolute Neutrophil Count Eligibility Criteria of Pediatric Phase I and Phase I/II Oncology Clinical Trials According to Sponsorship

Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia

Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia

Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials

Influence of Household Income on Health-Related Quality of Life in Children with Acute Myeloid Leukemia

Standardization in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL): Semiquantitative, Universally Applicable Flow Cytometric Criteria for Immunophenotypic Lineage Assignment and Isolated MPO

Comprehensive Secretome Profiling Elucidates Novel Disease Biology and Identifies Pre-Infusion Candidate Biomarkers to Predict the Development of Severe Cytokine Release Syndrome in Pediatric Patients Receiving CART19

Area-Based Socioeconomic Disparities in Survival of Children with Newly Diagnosed Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Reduced Relapse Risk in Children with Acute Myeloid Leukemia (AML) Who Experience Septic Shock (SS)

A Novel Approach to Identifying Septic Shock (SS) in Children with Acute Lymphoblastic Leukemia (ALL) Using Pediatric Health Information System (PHIS) Data: Methods Validation and Incidence Estimation in a National Cohort

Clinical Outcomes in Pediatric Mixed Phenotype Acute Leukemia (MPAL) Differ Depending on Disease Classification Criteria; A Multi-Center Cohort Study

Minimal Residual Disease Risk-Stratification in Pediatric Mixed Phenotype Acute Leukemia: Results of a Multi-Center Cohort Study

Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia

Using Administrative Data to Identify Relapse and Hematopoietic Stem Cell Transplantation (HSCT) in Children with Acute Lymphoblastic Leukemia (ALL): Validation at Two Centers and Incidence Estimation in a National Cohort

Increased Disease Burden Among Black Children Compared to White Children with Newly Diagnosed Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only